93 related articles for article (PubMed ID: 16959548)
41. The ataxia-telangiectasia mutated gene product regulates the cellular acid-labile sulfide fraction.
Islam MZ; Shen X; Pardue S; Kevil CG; Shackelford RE
DNA Repair (Amst); 2022 Aug; 116():103344. PubMed ID: 35696854
[TBL] [Abstract][Full Text] [Related]
42. Newly delivered transferrin iron and oxidative cell injury.
Breuer W; Greenberg E; Cabantchik ZI
FEBS Lett; 1997 Feb; 403(2):213-9. PubMed ID: 9042969
[TBL] [Abstract][Full Text] [Related]
43. Factors influencing survival of mammalian cells exposed to hypothermia. IV. Effects of iron chelation.
Zieger MA; Glofcheski DJ; Lepock JR; Kruuv J
Cryobiology; 1990 Aug; 27(4):452-64. PubMed ID: 2394129
[TBL] [Abstract][Full Text] [Related]
44. Molecular events contributing to cell death in malignant human hematopoietic cells elicited by an IgG3-avidin fusion protein targeting the transferrin receptor.
Ng PP; Helguera G; Daniels TR; Lomas SZ; Rodriguez JA; Schiller G; Bonavida B; Morrison SL; Penichet ML
Blood; 2006 Oct; 108(8):2745-54. PubMed ID: 16804109
[TBL] [Abstract][Full Text] [Related]
45. Evidence suggesting that iron and calcium are interrelated in oxidant-induced DNA damage.
Golconda MS; Ueda N; Shah SV
Kidney Int; 1993 Dec; 44(6):1228-34. PubMed ID: 8301924
[TBL] [Abstract][Full Text] [Related]
46. The effect of iron and iron chelators on the in-vitro block to development of the mouse preimplantation embryo: BAT6 a new medium for improved culture of mouse embryos in vitro.
Nasr-Esfahani M; Johnson MH; Aitken RJ
Hum Reprod; 1990 Nov; 5(8):997-1003. PubMed ID: 2127939
[TBL] [Abstract][Full Text] [Related]
47. Oxygen toxicity and chromosomal breakage in ataxia telangiectasia.
Joenje H; Nieuwint AW; Taylor AM; Harnden DG
Carcinogenesis; 1987 Feb; 8(2):341-4. PubMed ID: 2433071
[TBL] [Abstract][Full Text] [Related]
48. Effect of orally active hydroxypyridinone iron chelators on human lymphocyte function.
Pattanapanyasat K; Webster HK; Tongtawe P; Kongcharoen P; Hider RC
Br J Haematol; 1992 Sep; 82(1):13-9. PubMed ID: 1419787
[TBL] [Abstract][Full Text] [Related]
49. Telomeric associations and chromosome instability in ataxia telangiectasia T cells characterized by TCL1 expression.
Petrinelli P; Elli R; Marcucci L; Tabolacci E; Barbieri C; Antonelli A
Cancer Genet Cytogenet; 2001 Feb; 125(1):46-51. PubMed ID: 11297767
[TBL] [Abstract][Full Text] [Related]
50. Modulation of iron transport, metabolism and reactive oxygen status by quercetin-iron complexes in vitro.
Horniblow RD; Henesy D; Iqbal TH; Tselepis C
Mol Nutr Food Res; 2017 Mar; 61(3):. PubMed ID: 27794191
[TBL] [Abstract][Full Text] [Related]
51. [Effect of alpha-lipoic acid preparations on bilirubin and transferrin levels and ferritin iron and transferrin iron content].
Dudchenko NO; Mykhaĭlik OM; Lubianova IP
Ukr Biokhim Zh (1999); 2001; 73(2):102-5. PubMed ID: 11642031
[TBL] [Abstract][Full Text] [Related]
52. The use of iron chelators in biocidal compositions: evaluation of patent, WO2014059417A1.
Sahni S; Krishan S; Palanimuthu D; Richardson DR
Expert Opin Ther Pat; 2015 Mar; 25(3):367-72. PubMed ID: 25468449
[TBL] [Abstract][Full Text] [Related]
53. Effects of anti-transferrin receptor antibodies on the growth of neoplastic cells.
Kemp JD; Smith KM; Mayer JM; Gomez F; Thorson JA; Naumann PW
Pathobiology; 1992; 60(1):27-32. PubMed ID: 1543548
[TBL] [Abstract][Full Text] [Related]
54. Inhibition of iron-stimulated catecholamine degradation by the iron-chelators DETAPAC and Desferal. Potentially useful laboratory agents.
Heikkila RE; Cabbat FS
Biochem Pharmacol; 1981 Nov; 30(21):2945-7. PubMed ID: 6797434
[No Abstract] [Full Text] [Related]
55. Iron, free radicals and cancer.
Reizenstein P
Med Oncol Tumor Pharmacother; 1991; 8(4):229-33. PubMed ID: 1820488
[TBL] [Abstract][Full Text] [Related]
56. Multiple effects of iron chelators on molecules controlling cell cycle progression.
Gao J; Richardson DR
Transfus Sci; 2000 Dec; 23(3):247-8. PubMed ID: 11099904
[No Abstract] [Full Text] [Related]
57. Evaluation of recombinant human transferrin (DeltaFerrin(TM)) as an iron chelator in serum-free media for mammalian cell culture.
Keenan J; Pearson D; O'Driscoll L; Gammell P; Clynes M
Cytotechnology; 2006 May; 51(1):29-37. PubMed ID: 19002892
[TBL] [Abstract][Full Text] [Related]
58. Design, Synthesis, and Testing of Polyamine Vectored Iron Chelators.
Bergeron RJ; Singh S; Bharti N; Jiang Y
Synthesis (Stuttg); 2010; 2010(21):3631-3636. PubMed ID: 22013282
[TBL] [Abstract][Full Text] [Related]
59. Dual selective iron chelating probes with a potential to monitor mitochondrial labile iron pools.
Abbate V; Reelfs O; Kong X; Pourzand C; Hider RC
Chem Commun (Camb); 2016 Jan; 52(4):784-7. PubMed ID: 26567874
[TBL] [Abstract][Full Text] [Related]
60. Chromosomal breaks: another differential gap between early-onset and late-onset colorectal cancers.
Perea J; García JL; Corchete LA; Martí M; Hernández-Villafranca S; Alcázar JA; Álvaro E; Hurtado E; Jiménez-Toscano M; Balaguer F; Ballestero A; López-Rojo I; Jiménez F; Sanz G; Melone S; Brandáriz L; Vivas A; Alvarellos A; González-Sarmiento R;
Br J Surg; 2024 Mar; 111(3):. PubMed ID: 38430195
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
